
About August Bioservices
August Bioservices is a Healthcare company based in Nashville (United States) founded in 2017. Diversified research services for clinical solutions are offered. August Bioservices has raised $88.6 million across 3 funding rounds from investors including Oak HC/FT and Polaris Partners. The company has 86 employees. Its chief executive, as recorded, is Jenn Adams. August Bioservices offers products and services including cGMP Manufacturing, cGMP Laboratory Services, and Research and Development. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation. Its competitors include Exela Pharma, ApiJect and INCOG BioPharma Services; 3 of its 3 listed competitors have raised funding.
Company details
Provider of diversified research services for clinical solutions. The company provides services in the functional characterization development of assay and in-vitro services. Drug discovery, protein engineeringprotein therapeutics using cytokines, enzymes, fusion proteins, humanized monoclonal antibody, mAbs, and protein conjugates, and cell line development are provided. Formulation, process design, analytical method development solutions are available for pharma development. Labeling, kitting, and other support services are provided for clinical manufacturing.
- Headquarters Nashville, United States
- Employees 86
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website augustbio.com
- Social LinkedIn X
- Total Equity Funding$88.6M (USD)
in 3 rounds
- Latest Funding Round$65M (USD), Series B
Dec 2022
- InvestorsOak HC/FT
& 1 more
- Employee Count86
Products & Services of August Bioservices
August Bioservices offers a comprehensive portfolio of products and services, including cGMP Manufacturing, cGMP Laboratory Services, and Research and Development.
Handles sterile fill/finish for pharmaceuticals
Conducts analytical and extractables testing
Offers full programs for drug creation
Funding Insights of August Bioservices
August Bioservices has successfully raised a total of $88.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $65 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $88.6M
- Total Rounds 3
- Last Round Series B β $65M
- Investors Count 2
All 3 funding rounds of August Bioservices with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2022 | $65M | Series B | β | Oak HC/FT | |
| May 2021 | $23.6M | Series A | β | Polaris Partners, Oak HC/FT | β |
| Jul 2020 | Seed | β | Oak HC/FT | β |
2 investors in total: 2 institutional.
Investors in August Bioservices
August Bioservices has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Oak HC/FT and Polaris Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Investments are made in early-stage healthtech and fintech startups. | oakhcft.com | Stamford, United States | ||
US focused venture capital firm | polarispartners.com | Boston, United States |
Investor details for August Bioservices
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of August Bioservices
27 people are tracked at August Bioservices (11 in leadership, 16 in team); the tracked headcount is 86.
| Name | Role | Group |
|---|---|---|
Jenn Adams | CEO | Leadership |
Mike Scribner | Chief Operating Officer | Leadership |
Mats Bjoerkman | Chief Financial Officer | Leadership |
Jason Hartman | Vice President Operations | Leadership |
Ryan Downey | Sr. Director Of Technical Operations | Leadership |
Amanda Parker | Senior Director Project Management | Leadership |
Trent Cox | Vice President Manufacturing Operations | Leadership |
Renée Gray | Vice President Finance | Leadership |
Christine Hardesty | Associate Director, Quality Assurance | Leadership |
Michael Santowski | Vice President Supply Chain | Leadership |
Maeve McQuade | Senior Director Business Development | Leadership |
Jason Rhine | Sr. Automation Engineer | Team |
Jared Prater | Aseptic Process Engineer | Team |
M.D. Asfakur Rahman | Microbiologist III | Team |
Michael Foreman | Manager, Quality Audit Programs | Team |
Raxil Jogani | Senior Financial Planning And Analysis | Team |
Luis Maldonado | Quality Assurance AQL Lead | Team |
Chaitali Raskapur | Project Manager, Operations | Team |
Emily Weeks | Product Quality Assurance Manager | Team |
Sharell Ekinia-Collins | Financial Planning Analysis Manager | Team |
7 more people are available in the full profile.
Complete people profiles for August Bioservices
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of August Bioservices
3 dated milestones of August Bioservices across 5 years, from founding to its latest funding, stage changes and deals.
- Founded August Bioservices is founded.
- Funding First funding round.
- Funding Latest funding round, Series B, of $65.0M.
Competitors of August Bioservices
August Bioservices has 3 listed competitors in our database, 3 of them funded. They include Exela Pharma, ApiJect and INCOG BioPharma Services.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| exelapharma.com | 2005 | Lenoir, United States | $7.09M | 247 | Sterile injectable pharmaceuticals are manufactured alongside CDMO services. | |
| apiject.com | 2015 | Stamford, United States | $111M | Medicine injectors are manufactured by ApiJect for medical applications. | ||
| incogbiopharma.com | 2020 | United States | $86.63M | Injectable drug products are manufactured by this biopharma CDMO. |
Detailed competitors of August Bioservices
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of August Bioservices
The website of August Bioservices (augustbio.com) receives about 2.5K visits a month.
- Monthly visits2.5K
▼ 15.9% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as August Bioservices (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about August Bioservices
Complete news archive for August Bioservices
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about August Bioservices
August Bioservices was founded in 2017 and raised its 1st funding round 3 years after it was founded.
August Bioservices is headquartered in Nashville, United States. It is registered at Nashville, Tennessee, United States.
Jenn Adams is the CEO of August Bioservices, as recorded in our data.
August Bioservices is a funded company, having raised a total of $88.6M across 3 funding rounds to date.
August Bioservices has 86 employees.
Provider of diversified research services for clinical solutions. The company provides services in the functional characterization development of assay and in-vitro services. Drug discovery, protein engineeringprotein therapeutics using cytokines, enzymes, fusion proteins, humanized monoclonal antibody, mAbs, and protein conjugates, and cell line development are provided. Formulation, process design, analytical method development solutions are available for pharma development. Labeling, kitting, and other support services are provided for clinical manufacturing.
August Bioservices's top competitors include Exela Pharma, ApiJect and INCOG BioPharma Services.
August Bioservices offers cGMP Manufacturing, cGMP Laboratory Services, and Research and Development.
August Bioservices has 2 investors. Key investors include Oak HC/FT, and Polaris Partners.
